MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$22,854K
EPS
-$0.32
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
Research and development (includes related party amounts of 255, 249, 756 and 752, respectively)
17,706
22,266
General and administrative
7,168
7,067
Total operating expenses
24,874
29,333
Loss from operations
-24,874
-29,333
Interest income
2,055
2,367
Other expense
-10
-21
Total other (income) expense
2,045
2,346
Net loss
-22,829
-26,987
Unrealized gain (loss) on marketable securities
48
-152
Foreign currency translation
-73
246
Comprehensive loss
-22,854
-26,893
Basic EPS
-0.32
-0.38
Diluted EPS
-0.32
-0.38
Basic Average Shares
71,304,084
71,198,652
Diluted Average Shares
71,304,084
71,198,652
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$22,854K
Unrealized gain (loss) on
marketable securities
$48K
Interest income
$2,055K
Net loss
-$22,829K
Foreign currency
translation
-$73K
Total other (income)
expense
$2,045K
Other expense
-$10K
Loss from operations
-$24,874K
Total operating
expenses
$24,874K
Research and development
(includes related party...
$17,706K
General and
administrative
$7,168K
Buy us a coffee
Ventyx Biosciences, Inc. (VTYX)
Ventyx Biosciences, Inc. (VTYX)